Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Thursday, December 5, 2024 · 766,627,434 Articles · 3+ Million Readers

Alpha Emitter Global Market to Witness Exponential Growth Reaching $3.03 Billion by 2028 Amid Rising Incidence of Cancer

 Alpha Emitter Market

Alpha Emitter Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only!

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $3.03 billion in 2028 at a compound annual growth rate (CAGR) of 23.5%. ”
— The Business Research Company

LONDON, GREATER LONDON, UNITED KINGDOM, December 5, 2024 /EINPresswire.com/ --
The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

Can the Alpha Emitter Market Keep Up The Exponential Growth Seen In Recent Years?

The alpha emitter market has witnessed notable growth in the last few years, expanding from $1.06 billion in 2023 to an impressive $1.30 billion in 2024. This progress translates to a compound annual growth rate CAGR of 23.2%. The drivers fueling this growth during the historic period primarily include the surging incidence of cancer, enhanced research investments, favorable government support and funding, the rise in the aging population, and the expansion of radiotherapy centers.

What Is the Projected Market Size of the Global Alpha Emitter Market and Its Growth Rate?

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $3.03 billion in 2028 at a compound annual growth rate (CAGR) of 23.5%. The growth in the forecast period can be attributed to rising medical expenditure, the growing number of patients with cardiac ailments, growing use of combination therapies, the increasing prevalence of targeted alpha therapy, and increasing research and development activities. Major trends in the forecast period include advancements in imaging technologies, product innovations, strategic collaboration, advancements in radiopharmaceutical development, and development of new alpha-emitting isotopes.

Browse comprehensive market insights here: https://www.thebusinessresearchcompany.com/sample.aspx?id=19284&type=smp

What's Driving Growth for the Alpha Emitter Market?

The foremost growth propeller for the alpha emitter market is the escalating prevalence of cancer, which is expected to fuel the market significantly. Uncontrolled growth and spread of irregular cells in the body leading to tumors and tissue invasion characterize cancer. Aging populations, environmental exposure, transformed lifestyles, and improved detection methods contribute to the increasing prevalence of cancer. Leveraged in cancer treatment, alpha emitters aim to target and obliterate tumor cells precisely, while minimizing damage to surrounding healthy tissues. For instance, according to the Australian Institute of Health and Welfare, an Australia-based health administration, the number of Americans diagnosed with cancer, except basal cell carcinomas BCC and squamous cell carcinomas SCC of the skin, is estimated to rise from 151,000 in 2021 to 185,000 in 2030.

Gain exclusive insights into the full report: https://www.thebusinessresearchcompany.com/report/alpha-emitter-global-market-report

Which Key Players Are Dominating the Alpha Emitter Market?

Leading players operating in the market include Cardinal Health Inc., Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, Blue Earth Diagnostics Ltd., International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, ARTbio AS, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, Convergent Therapeutics, TAE Life Sciences, ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH, Fusion Pharmaceuticals Inc.

What Are the Noteworthy Trends in the Alpha Emitter Market?

The major industry trends feature an investment incline towards innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, aiding companies to maintain a competitive edge in the market.

Market segmentation reveals that the alpha emitter market in this report is dissected:

1 By Type Of Radionuclide: Radium, Actinium, Lead, Bismuth, Other Types Of Radionuclides
2 By Source: Natural Sources, Artificially Produced Sources, Other Sources
3 By Application: Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Lymphoma, Melanoma, Bone Metastasis, Other Applications
4 By End-User: Hospitals, Medical Research Institutions, Other End-Users

Regional Snapshot: Who Is Leading the Alpha Emitter Market?

In 2023, North America reigned as the largest region in the alpha emitter market. During the forecast period, Europe is predicted to be the fastest-growing region. The alpha emitter market report includes regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
5-Alpha Reductase Deficiency Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/5-alpha-reductase-deficiency-global-market-report
Alpha Glucosidase Inhibitors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alpha-glucosidase-inhibitors-global-market-report
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alpha-1-antitrypsin-deficiency-augmentation-therapy-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn

Powered by EIN Presswire

Distribution channels: Business & Economy, Companies, International Organizations, Technology, World & Regional

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release